Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Mar 25.
Published in final edited form as: J Mol Biol. 2008 Mar 18;378(5):1104–1115. doi: 10.1016/j.jmb.2008.03.017

Characterization of conformational and dynamic properties of natively unfolded human and mouse α-synuclein ensembles by NMR: implication for aggregation

Kuen-Phon Wu 1, Seho Kim 1, David A Fela 1, Jean Baum 1,*
PMCID: PMC3064448  NIHMSID: NIHMS252169  PMID: 18423664

Summary

Conversion of human α-synuclein (aS) from the free soluble state to the insoluble fibrillar state has been implicated in the etiology of Parkinson’s disease. Human aS is highly homologous in amino acid sequence to mouse aS which contains seven substitutions including the A53T substitution that is the same as the one that has been linked to familial Parkinson’s disease, and including five substitutions in the C terminal region. It has been shown that the rate of fibrillation is highly dependent on the exact sequence of the protein and mouse aS is reported to aggregate more rapidly than human aS in vitro. Nuclear magnetic resonance of mouse aS and human aS at supercooled temperatures (263K) is used to understand the effect of sequence on conformational fluctuations in the disordered ensembles and to relate these to differences in propensities to aggregate. We show that human and mouse aS are natively unfolded at low temperature but that they exhibit different propensities to secondary structure, backbone dynamics and long range contacts across the protein. Mouse aS exhibits a higher propensity to helical conformation at the C terminal substitution sites as well as the loss of transient long range contacts from the C terminal end to the N terminal and hydrophobic central region of the protein relative to human aS. Lack of back-folding from the C terminal end of mouse aS exposes the N terminal region which is shown, by 15N relaxation experiments, to be very restricted in mobility relative to human aS. We propose that the restricted mobility in the N terminal region may arise from transient interchain interactions suggesting that the N-terminal KTK(E/Q)GV hexamer repeats may serve as initiation sites for aggregation in mouse aS. These transient interchain interactions of the N terminal region coupled with a non-Aβ amyloid component (NAC) region that is both more exposed and has a higher propensity to β structure may explain the increased rate of fibril formation of mouse aS relative to human aS and A53T aS.

Keywords: Parkinson’s disease, α-synuclein, mouse, NMR, dynamics

Introduction

Natively unfolded proteins can adopt a variety of conformational states and interconvert between them on a wide range of time scales 1; 2. Identifying the range of conformations and timescales that can be accessed is important to understanding how natively unfolded proteins can be converted from their normally soluble form to insoluble fibers or plaques found in neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease (PD), Huntington’s disease and type II diabetes. Fluctuations within the ensemble of unfolded states are likely to be important in determining the pathway of folding to the aggregated form as conformational fluctuations provide a mechanism for different residues to come into contact with one another by exposing or protecting different regions of the protein to other proteins or to solvent.

Human aS is the primary protein component of the Lewy body deposits that are the diagnostic hallmark of PD 3. Aggregation of aS into fibrils is thought to play an important role in the pathogenesis of PD 4. The mechanism of conversion from soluble α-synuclein protein to amyloid fibril is proposed to arise via a nucleation dependent mechanism in which amyloidogenic proteins can access an unstable, partially ordered conformation prior to self assembly into insoluble protofibrils followed by the formation of amyloid fibrils 5; 6. Human aS is natively unfolded in solution but is composed of conformational ensembles that are on average more compact than those expected for a random coil protein 7, 8; 9; 10; 11.

Human aS is highly homologous in amino acid sequence to mouse aS, human β-synuclein (bS) and γ-synuclein (gS), and variants involved in early onset disease including the human aS with point mutations A53T 12, A30P 13 and E46K 14. The amino acid sequence of human aS can be divided into three regions including the N and C-terminal regions and the central NAC. The N-terminal region (residues 1-60) consists of 11-residue repeats with a highly conserved hexamer motif KTK(E/Q)GV. The charged C-terminal region (96–140) has a high percentage of aspartate, glutuamate, and proline residues and the NAC region is a hydrophobic region. It has been shown that the rate of fibrillization is highly dependent on the sequence of the protein as well as the solution conditions 15; 16; 17; 18. Mouse aS forms fibrils fastest relative to human aS, bS and gS as well as relative to the variants A53T and A30P involved in early onset of PD. Overall the rates of oligomer or fibril formation can be ordered from fastest to slowest in the order of mouse aS > human A53T aS > wt human aS > human A30P aS > gS > bS 6; 16; 19; 20.

Mouse aS with 95% sequence identity to human aS and faster aggregation kinetics in vitro provides a good system to understand the sequence determinants of the conformation and dynamics of the disordered ensembles and their relationship to aggregation. There are seven substitutions between human and mouse aS including the A53T substitution that is the same as the one that has been linked to familial PD (figure 1). There is a single S87N substitution in the NAC region and the remaining five substitutions are found in the C terminal region. One of C terminal substitutions, D121G, is at a position characterized as a key metal ion binding site in human aS 21. Structural characterization of mouse aS by CD shows a natively unfolded state in solution 16 but little is known about the nature of the conformational ensembles that populate mouse aS.

Figure 1. Sequence alignment of human and mouse aS.

Figure 1

Sequence alignment of human and mouse aS from the program ClustalW. Sequences of human and mouse aS are denoted as human and mouse, respectively. The seven non-identical residues in the mouse aS sequence are indicated, and identical residues to human aS are denoted by dots. The six KTK(E/Q)GV repeats are displayed in boxes and the NAC region (residues 61 to 95) is colored in red.

Comparison of the conformational fluctuations of human and mouse aS by nuclear magnetic resonance (NMR) at supercooled temperatures (263K) are reported here in order to understand their sequence dependence and to relate these to the kinetics of fibril formation. Low temperatures were selected in order to freeze out motions and more clearly define the extent of restricted motion and nonrandom interactions in both proteins. 15N backbone relaxation experiments which are sensitive indicators of local conformational restriction on the ps to ms timescale and paramagnetic relaxation enhancement (PRE) experiments which allow the determination of long range conformational contacts were correlated and show that mouse aS populates more extended conformations in solution than human aS. The NMR data indicate that regions of restricted mobility in human aS are correlated with regions that have transient long range contacts to the C terminal end of the protein whereas restricted mobility in mouse aS, which is prominent in the N terminal region, does not show this correlation. The increased backbone motional restriction of the N terminal region coupled with the flexible NAC region with a higher propensity of β conformation may explain the increased rate of fibril formation of mouse aS relative to human aS.

Results

Backbone assignments of human and mouse aS at low temperature

The 1H-15N resonances of human and mouse aS are well resolved and have narrow chemical shift dispersion typical of natively unfolded proteins (figure 2). Backbone assignments of human and mouse aS were performed using a series of triple resonance experiments. Assignments were originally performed at 288K using standard triple resonance experiments 22 including HNCACB, CBCA(CO)NH, HNCO, HN(CA)CO, and C(CO)NH as well as (5,3D) HACACOCANH and (5,3D) HACACONH GFT-NMR 23; 24 in order to overcome ambiguities that arise in the standard experiments. Certain segments of the KTK(E/Q)GV repeats and several double repeats (AA, VV, GG, and EE) were not able to be assigned due to overlap. In total, 118 resonances of the 134 assignable residues have been assigned for mouse aS and 117 residues assigned for human aS. Low temperature (263K) spectra were assigned by a temperature titration and the assignments confirmed by HNCACB experiments. Comparison of the 1H-15N chemical shifts of human and mouse aS indicates only small differences near the substitution sites indicating that there is no large global conformational change that takes place between the two proteins.

Figure 2. 1H-15N HSQC spectra of human and mouse aS at 263K.

Figure 2

1H-15N HSQC spectra of human aS (a) and mouse aS (b) at 263K. Both aS were dissolved in PBS buffer (8 mM Na2HPO4, 2 mM KH2PO4, 2.7 mM KCl, and 137 mM NaCl) at pH 7.4. Assignments are indicated on the figure.

Secondary structure propensities of human and mouse aS at 263K

NMR chemical shifts are frequently used to probe the propensity of natively unfolded proteins to sample different regions of conformational space 7; 10; 25; 26; 27; 28. Kim et al have reported averaged Cα and C′ chemical shifts for human aS at −15 °C and show that residues 38-98 as well as the C terminal residues have predominantly negative chemical shifts 29. Here we use the secondary structure propensity score (SSP) that has been used for the comparison of human aS and gS at 5 °C to compare the propensity to secondary structure of human and mouse aS at low temperature 26.

Although there are only minor differences in the 1H-15N HSQC spectra between human and mouse aS at low temperature, the SSP profile shows certain important differences between the two proteins (figure 3). The SSP profile of human aS shows very little propensity to helical conformation along the protein sequence, but does show a mild propensity of β conformation from residue 30 to 140. In contrast, mouse aS shows more propensity overall of secondary structure with some helical propensity at positions 33–37, at the substitution site A53T and at residues 100 to 105 which include substitutions sites L100M, N103G and A107Y. In addition, mouse aS shows more propensity to form β conformation in particular in the NAC region at residues 75 to 82 and 85 to 97 and in the N terminal region from residues 25-30. Many of the SSP changes occur in the regions around the substitution sites indicating that local conformational propensities are sensitive to the substitutions. However there are also changes in SSP in regions that contain no substitutions such as the changes for residues 33-37 in the N terminal region.

Figure 3. Secondary structure propensity (SSP) of human and mouse aS at 263K.

Figure 3

Cα and Cβ chemical shifts were used to calculate the residue-specific SSP scores of human aS (a) and mouse aS (b). Positive values ranging from 0 to 1 and negative values from 0 to −1 represent the propensities of α and β structures, respectively. A schematic of the sequence containing the positions of the repeats and the point substitutions are indicated on top with repeats shown with green boxes and point substitutions shown by blue lines. The red dashed lines indicate the separation of the N-terminal, NAC and C-terminal regions.

Mouse aS exhibits restricted backbone dynamics in the N terminal region and increased flexibility in the NAC region relative to human aS

15N relaxation experiments (figure 4) are performed to explore the dynamics of the natively unfolded states of human and mouse aS on the fast ps-ns timescales as well as on the slower millisecond timescale. In human aS the R1 data are extremely uniform across the sequence whereas the R2 data show distinct regions of variability (figure 4a, 4c). The R2 data range from 8.0 sec−1 which are approximately the values expected for the random coil values 30 and increase to values as high as 13 sec−1 suggesting that human aS has significant heterogeneity in backbone dynamics at low temperature. In order to define the variable regions in the R2 data, locally weighted scatterplot smoothing fitting (LOESS) 31 has been performed to smooth the R2 data and five qualitative clusters of deviations from the random coil R2 have been assigned to the sequence (Table 1). Clusters I and II in the N terminal end from residues 11 to 31 and 37 to 64 respectively display increased R2 values on the order of 8 sec−1 and 14 sec−1. Cluster III which is in the NAC region is clearly defined by low R2 values at the two edges and increased values in the center. Cluster IV at the C terminal edge of the NAC region displays relatively flat R2 values consistent with random coil like R2 values and the final cluster V shows increased values for R2 on the order of 10 sec−1 to 11 sec−1. 1H-15N NOE data are in the range of 0.5 and are relatively uniform across the sequence; there is a small dip around residues 107 to 116 (figure 4e).

Figure 4. 15N Relaxation parameters of human and mouse aS at 263K.

Figure 4

The relaxation data R1(a), R2 (c), 1H-15N NOE (e) and Rex (g) of human aS and the relaxation data R1(b), R2 (d), 1H-15N NOE (f) and Rex (h) of mouse aS at 263K are shown in the left and right panels, respectively. 150~200 μM samples were freshly prepared to record the four relaxation experiments for each aS on a Varian 800MHz NMR spectrometer. The schematic of the sequence is placed above the data to show the positions of KTK(E/Q)GV repeats and the seven non-identical point substitutions. R1 plots of human and mouse aS are presented in panels (a) and (b), correspondingly. Relaxation rates calculated for a random coil 30 are presented in both human and mouse aS R2 plots (c, d) to provide a baseline. Smoothing curves (red) of human and mouse aS were calculated by using a locally weighted scatterplot smoothing method (LOESS) with a span of 5 points. Clusters derived from the deviation of the smoothed curves relative to the calculated random coil values are denoted beneath the experimental R2 values. 1H-15N NOE plots of human and mouse aS are shown in (e) and (f) respectively. Rex plots (g,h) were obtained from the difference of R2HE -κηxy experiments where κ is 1.22 ± 0.01 for both human and mouse aS (see Methods). Error bars are shown for every three points and for any point with Rex values greater than 2.5 for clarity.

Table 1.

The local clusters defined by R2 profiles of human and mouse aSa.

No. of clusters Human α-synuclein Mouse α-synuclein
I A11 ~ G31 L8 ~ Q33
II V37 ~ T64 V37 ~ T64
III G73 ~ G86 N/Ab
IV V95 ~ L100 F94 ~ M100
V G111 ~ M127 E105 ~ Y133
a

Local nonrandom structural clusters are characterized based on the R2 values greater than 8.5 sec−1 at supercooled temperatures. The first and last residues of each cluster are indicated by types of amino acid and position numbers for each aS.

b

This cluster was defined according to human aS since mouse aS has near random coil R2 values at this region.

15N relaxation experiments in mouse aS show similar features to human aS in R1 values (average is 1.48 ± 0.14 sec−1 and 1.49 ± 0.12 sec−1 in human and mouse respectively) but significantly different patterns and amplitudes in the R2 values with values ranging from 8 to 16 sec−1 and average values of 8.74 ± 1.72 sec−1 and 9.50 ± 1.96 sec−1 for human and mouse aS respectively (figure 4b, 4d). Cluster I in the N terminal region is highly elevated relative to the random coil values (R2 values on the order of 12 sec−1 to 16 sec−1) and relative to the same cluster in human aS. Cluster II with some restricted mobility appears to be similar to cluster II in human aS. Cluster III in the NAC region shows values that are very close to the random coil indicating a flexible region in mouse different from the NAC region in human aS that has more restricted mobility. Cluster IV in mouse aS just C terminal to the NAC region has increased R2 values relative to the same region in human and cluster V in the charged C terminal has slightly larger R2 values over a wider of residues (from 94 to 100 in mouse versus 95 to 100 in human aS). The 1H-15N NOEs average values of human and mouse aS are similar with 0.47 ± 0.08 and 0.49 ± 0.08 respectively. 1H-15N NOE values are slightly elevated relative to human aS in the N terminal region but slightly decreased in the NAC and C terminal regions indicating restricted motion in the N terminal region (figure 4f).

Elevated R2 relaxation rates indicate increased lower frequency motions or slower backbone motions which could arise from a number of factors including restricted motion due to transient secondary structure, local clustering effects, clustering effects due to long-range contacts, or conformational exchange in the μs to ms timescale 32; 33. In order to identify whether residues that have elevated R2 rates are undergoing conformational exchange on the μs-ms timescale and to derive the chemical exchange rate (Rex) for these residues, the difference of two experiments is required. One experiment, the ηxy (CSA/dipolar cross-correlation rate) experiment 34; 35 is designed to quantify the intrinsic (R20), which is the condition under which chemical exchange is totally suppressed and the second experiment, the in-phase Hahn echo experiment (R2HE) 36; 37 is designed to measure R2 under conditions where the full exchange contribution to relaxation is obtained. Rex values derived from the difference in these two experiments shows that for human aS Rex are primarily in the range of −1 ~ 1.5 (sec−1) suggesting minimal or no chemical exchange across the protein sequence (figure 4g). The Rex values of human and mouse aS are very similar suggesting that differences in the R2 values do not arise from differences in chemical exchange in the μs-ms timescale for these proteins at low temperature (figure 4h). In both proteins, Ser, Thr and Gly residues tend to have slightly higher Rex values closer to 2.5 sec−1 which is seen for example with residues G41, S42 and T44 (Rex values of 2.5 to 3.5 sec−1). The higher Rex values of Gly, Ser and Thr may be related to solvent water exchange and experiments are underway to investigate this relationship. There are a very small number of residues that have larger exchange rates on the order of 5 sec−1, in particular residues A27 and T59 in human and mouse aS.

Because of the minimal nature of the chemical exchange and the similarity of the Rex values in the two proteins, the difference in the R2 rates in human and mouse is attributed primarily to a clustering effect or to transient secondary structures. The most significant differences between the R2 values of human and mouse aS are seen in the more rigid N terminal region and more rigid cluster IV just C terminal to the NAC region and the more flexible NAC region of mouse aS.

Long-range interactions from the C terminal to the N terminal and hydrophobic NAC region are eliminated in mouse aS

Paramagnetic relaxation enhancement (PRE) experiments have been used to locate residual long range interactions in natively unfolded human aS, bS and gS 8; 9; 10, 29. PREs are employed here to map the tertiary long range contacts of human and mouse aS at low temperature (figure 5). Two positions, A19 and G132, were chosen to construct a cysteine mutation in human and mouse aS. The spin label nitroxide, (1-oxy-2,2,5,5-tetra-methyl-3-pyrroline-3-methyl)-methanesulfonate (MTSL), was conjugated to the thiol group of Cys by forming a disulfide bond. The peak linewidth of the amide proton becomes broadened when the distance of the HN-to-MTSL is within 25 Å of another residue and PRE effects (Ipara/Idia) can be easily observed by acquiring HSQC spectra in the oxidized or reduced state of the MTSL spin label.

Figure 5. Paramagnetic relaxation experiments of amide protons in human and mouse aS.

Figure 5

PRE experiments using MTSL spin labels were done at 263K for cysteine mutants human A19C aS (a), human G132C aS (b), mouse A19C aS (c) and mouse G132C aS (d). Measured PRE intensity ratios (Ipara/Idia) of human and mouse aS are presented in top and bottom panels, respectively. N-terminal, NAC and C-terminal regions are colored light blue, orange and green respectively. Red dashed lines in each plot show the broadening expected from a random coil polypeptide (see Methods) to provide a reference to map long-range contacts. Smoothing curves were calculated by using LOESS with a span of 5 points and they are shown in thin lines over the colored bars.

Spin labeling of the N terminus at residue A19C (figure 5a) leads to weak signal attenuation across most of the protein except for residues at the edge of the C terminal which have signal attenuation on the order of Ipara/Idia of 0.8 and signal attenuation in a small region of the N terminal at approximately residue 50. Placing the spin label at position G132C in the C terminal region (figure 5b) shows that human aS exhibits a wide range of transient long range contacts from the C terminal end to the rest of the protein. In particular, there is strong signal attenuation, in the range of Ipara/Idia of 0.6–0.7, just C terminal to the NAC region at residues 92 to 100 and at the N terminal region of the protein at residues 37 to 53. In addition to these strong regions of signal attenuation there is also weaker signal attenuation across the entire protein sequence in the range of Ipara/Idia of 0.8 suggesting that the C terminal end of the protein is making transient contact with many regions of the rest of the protein.

Although human and mouse aS have some PRE effects in common, they have very different long range interactions between the C terminus and the rest of the protein. With the spin label attached at residue 132 (figure 5d), comparison of mouse and human aS shows that the strong signal attenuation to the N terminal region at positions 30 to 50 is maintained as well as the strong signal attenuation C terminal to the NAC. However human and mouse aS show a difference in the signal attenuation at the N terminal between residues 10 and 30, at positions 60 to 90 in the NAC region and at positions 100 to 110 in the C terminal region. In mouse aS, there is no signal attenuation in these three regions indicating that the C terminal is not interacting with the first two hexamer repeats of the N terminal region, the majority of the NAC region or the small region at position 100 just C terminal to the NAC region. Labeling at the N terminal end at residue A19C shows more subtle differences between human (figure 5a) and mouse aS (figure 5c). Overall there is less signal attenuation in mouse aS than human aS with exposure of the NAC region. The differences in the signal attenuation of the C terminal spin label in mouse and human aS suggests that the long range contacts within the two proteins differ from one another. In particular, there is elimination of long range interactions from the C terminal end to the hydrophobic NAC region and the N terminal region in mouse and the transient interactions from the C-terminal end to these regions are eliminated in mouse aS relative to human aS.

Pulse field gradient NMR translational diffusion experiments are performed on human and mouse aS in order to obtain the hydrodynamic radius of the proteins at low temperature 38. Mouse aS has a greater hydrodynamic radius (Rh = 29.5 Å) than huam aS (Rh= 28.1 Å) indicating that mouse protein is less compact than human aS. These results are consistent with the PRE experiments that show fewer long range contacts from the C terminal end of mouse aS to the NAC and N terminal region relative to human aS.

Discussion

There is significant interest in the conformation and dynamics of human aS, its homologs bS and gS as well as the variants that contain single substitutions that result in early onset disease. Understanding the role and sensitivity of sequence changes to the nature of the conformational ensembles of these natively unfolded proteins has provided insight into the propensity of different synucleins to aggregate and form fibrils 8; 9; 10; 11; 25; 26; 29. Mouse aS with only seven substitutions relative to human aS is a good system to identify the role of a small number of residues in redistributing the conformational fluctuations relative to human aS. Backbone relaxation experiments and PRE experiments at high temperature (288K) showed only very small differences between the two proteins (unpublished data) but significant differences were observed at supercooled temperatures (263K) allowing a more detailed investigation of the differences between the conformational ensembles of human and mouse aS.

Working at low temperature may shift the thermodynamics or the kinetics of the system or both. This will result in changes in distributions of populations and/or changes in the kinetics of inter-conversion towards conformational ensembles that are less averaged and more easily characterized by NMR relaxation and PRE methods. In the kinetic limit, the effect of the low temperature will be to induce changes in inter-conversion rates between the conformers allowing the characterization of the same states that are present at physiological temperatures. In the thermodynamic limit, there may be a shift in the population balance toward a more easily characterized state. While that state may not be the major conformation at physiological temperatures undoubtedly it still has some significant population and is energetically accessible at high temperature. Therefore, these low temperature conformations may provide novel insight into the types of interactions that can exist in aS conformers but that may be difficult or impossible to detect under high temperature conditions.

Correlation of long range transient contacts and restricted mobility in human aS

Despite the similar amino acid sequences of human and mouse aS, NMR measurements indicate that restricted mobility on the ps-ns timescale and long range contacts within the proteins are significantly different from one another. A schematic illustration of the combined R2 and PRE effects of human and mouse aS illustrates the differences between them (figure 6). PRE effects are shown by a color gradient with dark blue indicating a strong loss of signal intensity and red indicating no loss of signal intensity from the PRE probe. Human aS has a wide range of C terminal contacts along the protein as evidenced by the primarily blue/light pink tone of the human sequence. Regions of most contact to the C terminal probe include cluster II and cluster IV, with other regions showing lighter colors suggestive of interactions that are not as strong but that still exist transiently. In human aS there is a strong correlation between regions of restricted mobility and the PRE from the C-terminal label to the rest of the protein. The PRE effects are primarily in regions that have been identified as having restricted mobility from the R2 data (residues represented as surface residues). The residues that are identified as mobile on the ps-ns timescale (residues shown in stick), such as the edges of the NAC region which are composed of Gly residues and the residues in the C terminal end, have weaker PRE contacts from the C terminal end (pinker color). This correlation between the regions of restricted mobility and the strong signal attenuation from the spin label suggests that the restriction of motion in clusters I, II and III and IV arises predominantly from the long range contacts with the C terminal end and that restriction of motion arises primarily from transient clustering of residues within the protein.

Figure 6. Model representations of structural clusters and long-range contacts of human and mouse aS.

Figure 6

Schematic illustration along the protein sequence of the combined R2 and C-terminal PRE data for human (top) and mouse aS (bottom). Residues assigned to clusters derived from R2 data (clusters are shown in figure 4b and 4d, and defined in table 1) are illustrated in surface and residues that do not belong to clusters are shown in stick. Experimental PRE values from 1.0 to 0.5 are represented by a color gradient of red to white to yellow. This model was made by PyMOL 0.99 (http://pymol.sourceforge.net).

The picture that emerges from our data for human aS at low temperature is one for which the C terminal end of the protein makes contact with many different parts of the protein suggesting that aS is composed of a large number of different compact structures that populate the ensemble averaged conformation. Previous studies by Kim et al have suggested that the effect of low temperature is to remove the transient long range interactions in human aS 29. This is based on the measurement of the hydrodynamic radius of human aS at −15 °C which is increased relative to high temperature, and PRE experiments from the N terminal labels that show minimal long range interactions. Our measurements at −10 °C have shown similar PRE results to Kim’s with the spin label at the N terminal region, however additional experiments where the PRE probe is placed at the C terminal end extend the data and show that human aS exhibits a wide range of transient long range contacts from the C terminal end to the rest of the protein. At this point we propose that the discrepancy between the two laboratories may be due to measurement under different solution conditions; in particular measurement under very different buffer/salt concentrations (Kim 50mM phosphate buffer, pH 7.4, 300 mM NaCl; Wu 10mM phosphate buffer, pH 7.4, 137mM NaCl). Fink et al. have shown that the rate of fibrillation of human aS is extremely sensitive to salt concentration suggesting that the two laboratories may be investigating distinct conformational ensembles due to the dissimilar salt conditions 39. Further work is required to clarify these issues.

Loss of long range contacts in mouse aS relative to human aS

In contrast to human aS, mouse aS does not exhibit a strong correlation between regions of restricted mobility as defined by increased R2 values and the PRE effects from the C terminal end. The large cluster at the N terminal end, cluster I, shows the most restricted backbone mobility and yet has no PRE contacts with the C terminal end. A second region that exhibits markedly different behavior from human aS is the flexible NAC region which also does not have any long range contacts with the C terminal end of the protein as observed by PRE experiments. Decreased contacts from the C terminus allows both the NAC and the N terminus to be exposed; however these two regions show very different degrees of restricted motion with the NAC region flexible, while the N terminus is highly restricted in motion. In addition, the NAC region shows increased propensity to β conformation while cluster I of the N terminal shows little propensity to secondary structure. It has been suggested that residual helical propensity in the N terminal region in human aS may stabilize long range interactions and interfere with intermolecular association 10. In mouse aS, the converse may be true where the destabilization of the N terminal helical propensity along with the absence of long range contacts to the C-terminal end may increase aggregation rates. In contrast to human aS the picture that emerges for mouse aS is one that has fewer C terminal contacts across the protein, may have missing elements of the ensemble relative to human aS and fewer compact structures that populate the ensemble averaged conformation. The larger hydrodynamic radius of mouse aS relative to human aS is consistent with this picture.

The lack of correlation between regions of restricted mobility and C terminal long range contacts suggests that the restricted mobility of the N terminal region in mouse does not arise through a clustering effect from transient long range intra-chain interactions but rather may arise from transient secondary structure, a local clustering effect or transient aggregation. Examination of the SSP data does not indicate a high propensity to secondary structure in cluster I and Rex data does not show significant restricted mobility due to chemical exchange on the ms timescale in this region. In addition, it is unlikely that the restricted mobility arises from long range intra-chain interactions as there are no other regions of the protein that exhibit the same magnitude of R2 values. In light of the lack of secondary structure propensity and the lack of a long range interactions, suggestions for the origin of the N-terminal slower backbone motions of cluster I may be from back folding of the hexamer repeats or from transient protein-protein aggregation at the N terminal end.

Implications for aggregation

Conformational and dynamics comparison of human and mouse aS are undertaken in order to determine the differences between the natively unfolded ensembles of the proteins and to relate these to the aggregation propensities of the proteins. It has been hypothesized that the C-terminal region of aS acts like a binding partner and interacts with the repeating fragments of the N terminal and the hydrophobic NAC region 40 It has also been shown that C-terminal truncation variants aggregate much faster than the wild type confirming that the C terminal end is important for directing fibril formation 41. In mouse aS, substitutions in the C terminal end, L100M, N103G and A107Y enhance the propensity to α-helical conformation at residues 100 to 104 and show restricted mobility. In human aS, the same region is very flexible based on R2 data. The extent of broadening due to the C terminal spin label between residues 100-104 is greater in human versus mouse synuclein suggesting that the sequence changes in mouse are responsible for the altered secondary structure and increased rigidity. The limited flexibility and the secondary structure propensity of residues 100-104 (the N-terminal end of cluster V) in mouse versus human aS may be a key determinant in preventing the C-terminal region of the mouse aS from interacting with the N terminal region.

The loss of long-range interactions to the NAC region in mouse aS at low temperature is similar to what is observed for the familial mutations of human aS, A30P or A53T mutations at high temperature 42. Because the A53T mutation exists in mouse aS it is interesting to compare the single mutation variant to mouse aS. It has been proposed that the A53T mutation may stabilize alternative structures relative to the folded over structures and shift the population of conformers away from the folded over structures towards conformational ensembles that are more likely to aggregate 42. The same destabilization mechanism may be important for mouse aS but in addition, the increased rigidity of the “hinge” region (cluster IV) between the C terminal and the rest of the protein that arises from the L100M, N103G and A107Y substitutions further enhances the exposure of the NAC and N terminal. We propose that the restricted mobility in cluster I of the N terminal region may arise from transient interchain interactions suggesting that the N-terminal KTK(E/Q)GV hexamer repeats may serve as initiation sites for aggregation in mouse aS. Increased interaction between the N terminal regions suggests a lower barrier to aggregation. These N terminal repeats have been shown to be very important as deletion or removal of N terminal repeats impacts dramatically on the rate of fibril formation 43. Another factor that has been suggested to be important for the rate of fibril formation is the extent of secondary structure propensity in the NAC region 11; 26. It appears that the sequence of mouse aS optimizes the effects that are important for rapid fibril formation; transient interchain interactions of the N terminal region coupled with a NAC region that is both more exposed and has a higher propensity to β structure may explain the increased rate of fibril formation of mouse aS relative to human aS and A53T aS.

Material and methods

Chemicals

15N labeled ammonium sulfate, 13C labeled glucose and deuterium dioxide were purchased from Cambridge Isotope Laboratory (Andover, MA). MTSL (1-oxy-2,2,5,5-tetra-methyl-3-pyrroline-3-methyl-methanesulfonate)was purchased from Toronto Research Chemicals (Toronto, On, Canada) and all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO).

Protein preparation

Plasmids (pT7-7) encoded human and mouse aS cDNA sequences were gifts from Dr. Peter Lansbury (Harvard medical school, Cambridge, MA) and were transformed into Escherichia coli BL21 DE3 strain (Invitrogen Inc.). Expression and purification of aS followed the published protocols 44. For the preparation of NMR samples, dried proteins were dissolved to run size-exclusion gel filtration using a HiPrep 26/60 superdex 75 column (GE healthcare, Piscataway, NJ) if the gel electrophoresis result showed dimers or oligomeric aS. The purity of aS was verified again by gel electrophoresis as a single band at 14.5 kDa.

NMR experiments

For NMR experiments in supercooled water at 263K, samples were prepared following the published protocols 45; 46. The proteins were dissolved in standard phosphate buffered saline (PBS: 8 mM Na2HPO4, 2 mM KH2PO4, 2.7 mM KCl, and 137 mM NaCl) at pH 7.4 and transferred into four 1.7 mm (outer diameter) capillary tubes (Wilmad labglass, Buena, NJ) and all capillary tubes were put into a regular 5 mm NMR tube with a cap. All NMR experiments were recorded at 263K on a Varian 800MHz spectrometer equipped with a warm probe. NMR data were processed with NMRPipe 47 with zero-filling and linear prediction if needed. Processed spectra were converted to NMRView 48 or Sparky 49 file format for data analysis. Proton chemical shifts were referenced to DSS as 0.00 ppm and 15N and 13C chemical shifts were indirectly calibrated by the gyromagnetic ratios 50.

The assignment of 1H-15N HSQC spectra and sequential assignments of human and mouse aS were first carried out at higher temperature (288K). Assignment of low temperature (263K) 1H-15N HSQC spectra of human and mouse aS were done by monitoring the movement of each cross-peak from 288K to 263K and also by using HNCACB to confirm the assignment. The secondary structure propensity (SSP) program has been developed by Marsh et al and gives a measure of the secondary structure populated26. The SSP scores of human and mouse aS were calculated using calibrated Cα and Cβ chemical shifts at 263K as inputs.

150–200 μM samples were prepared for each 15N backbone relaxation experiment. 1H-15N steady state heteronuclear NOE (1H-15N NOE), longitudinal relaxation (R1) and transverse relaxation (R2) experiments of human and mouse aS were recorded. 1H-15N steady-state heteronuclear NOE values at 263K were measured by recording spectra with or without a 1H saturation period of 3 seconds. The uncertainties in the measured peak-height were set equal to the root-mean square baseline noise in the spectra, and the errors in 1H-15N NOE were the standard deviation of the two sets 51. R1 experiments were collected using the following relaxation delay times (in seconds) in a random order: 0.01, 0.05, 0.09, 0.17, 0.36, 0.49, 0.73, 1.01, 1.31, 1.80. R2 experiments were collected used the CPMG (Carr-Purcell-Meiboom-Gill) pulse train 51, with an inter-pulse delay of 625 μs and the relaxation delay times used were 0.01, 0.03, 0.05, 0.07, 0.09, 0.13, 0.17, 0.21, 0.25 seconds. Two points were duplicated to have the proper error ranges for the R1 and R2 experiments. Recycle delays of R1 and R2 experiments are 2 seconds.

Chemical exchange Rex was measured by taking the difference of two experiments; the in-phase Hahn echo experiment (R2HE) 36; 37 and the ηxy (CSA/dipolar cross-correlation rate) experiment 34; 35. Similarly to the R2 experiment, R2HE experiments were performed by using several relaxation delays ranging from 15 ms to 150 ms. The relaxation rates wereextracted by fitting the peak intensities to the equation I(t)= I0 exp(−R2t) using the fitting function of Sparky. Relaxation delays and the recycle delay of the ηxy experiments at 263K were 46.08 ms and 2 seconds, respectively. Each ηxy experiment was divided into two 1H-15N HSQC type spectra and the ηxy values was determined by following equation:

IcrossIauto=tanh(ηxyτHE) (1)

Icross and Iauto are the peak intensity of cross- and auto- relaxation, respectively. τHE = n/JNH, where n is a positive integer (6 for 263K experiments) and JNH is the scalar coupling constant of amide bond (93 Hz). Two more ηxy experiments were performed to get the average and standard error of the mean of each residue.

Rex was defined as Rex = R2HE − R20, where R20 = κηxy, and κ is an average value of the ratio of R2HExy for those residues not subjected to chemical exchange. To obtain the κ value for human and mouse aS, weighted correlation fittings of R2HE and ηxy were calculated. Residues with differences of R2HE and ηxy greater than 2.5 were not included in the correlation fitting. The calculated κ values for both human and mouse aS are 1.22 ± 0.01.

The model of the theoretical R2 values of a random coil like polypeptide chain was calculated as previously proposed 30. R2 values were fitted to the following equation:

R2(i)=R2intj=1nexp((ij)λ) (2)

where R2int is the intrinsic R2, n is the residue numbers of the protein (140 for aS), λ is the widow size of the persistence of the protein. For fitting the 263K R2 data, R2int and λ are 0.33 and 12, respectively to provide a nice baseline.

Locally weighted scatterplot smoothing fitting (LOESS) 31 was used to smooth the R2 data of human and mouse aS in order to define local deviations from the random coil R2 values. Calculations of LOESS were performed by the curvefit toolbox of Matlab (The Mathworks Inc.) with a 5-point span.

Samples for measuring hydrodynamic radius (Rh, in angstroms) were dissolved in 90% D2O (v/v) PBS at pH 7.4. The DOSY pulse sequence (Dbppste_cc) 38 in Varian BioPack library was used to obtain the translational diffusion coefficients (Dtrans) of 0.2 mM human and mouse aS at 288K and 263K. Data was processed and analyzed by VNMRJ 2.12B. Convection compensation 52 was applied to correct the temperature effects on Dtrans. Dtrans of 1,4-dioxane (1 mM in PBS) was also measured at both temperatures as a reference molecule for calculating the Rh of human and mouse aS. Since both aS and 1,4-dioxane are dissolved in the same solution, it is not necessary to determine the viscosity to obtain Rh from the Stoke-Einstein equation. Rh of human and mouse aS can be calculated from the relationship:

Rhprotein=(Dtransdioxane/Dtransprotein)Rhdioxane (3)

where Rhdioxane is 2.12 Å and Dtransdioxane and Dtransprotein are measurable parameters.

Site directed spin labeling and paramagnetic relaxation enhancement (PRE) experiments

Two mutants were successfully constructed to replace the residues to cysteine (A19C and G132C) for each aS. DNA sequences were verified and proteins were expressed and purified as described for wild type aS. 5 mg lyophilized protein was dissolved in 1 ml PBS with 10 mM DTT and at least 4 hours incubation at room temperature to remove the disulfide bonds. The solution was transferred to a desalting column (GE Healthcare, Piscatway, NJ) to remove DTT. The DTT-free solution was immediately added to a 20-fold molar excess MTSL solution which was dissolved in acetone. The spin labeling reaction ran in the dark at 4 oC for 16 hours or more and then the sample was concentrated to 250 μM for NMR experiments. The molecular weights of the four cysteine mutants and the four spin labeled samples were verified by ESI Mass spectroscopy.

PRE experiments were performed by acquiring 1H-15N HSQC spectra in the absence and presence of MTSL spin labeling of each cysteine mutant. PRE experiments were first acquired at 288K to confirm the consistency of the published data 8; 10, then samples were quickly cooled to run data collection at low temperature. To control the reference more accurately, reference samples were prepared by adding DTT to the MTSL spin labeled samples after the MTSL-labeled 1H-15N HSQC acquisition. It should be noted that DTT-added solutions were kept at room temperature for 2–3 hours for complete reaction of removing the conjugated MTSL. Assigned peak intensities were extracted by Sparky to calculate the PRE ratios (Ipara/Idia) in the presence or absence MTSL attachment.

Theoretical PRE curves were calculated by using XPLOR-NIH 53 to generate MTSL-attached fully extended structures. From these, Ipara/Idia PRE values were calculated and used as a reference for an unfolded protein with no long-range interactions 54. To aid the eye the PRE data was smoothed using the LOESS approach similarly to the R2 data. Since LOESS takes every 5 points to calculate and smooth the curve, residues in the predecessor or the successor positions of the A19C or G132C data were not included to perform fitting, respectively.

Acknowledgments

We acknowledge helpful discussions with Dr. David Talaga and Dr. Ron Levy. We thank Dr. Peter Lansbury for providing the human and mouse aS constructs. K.-P. Wu is supported by an NIH Interdisciplinary Research Workforce Fellowship.

Abbreviations

NMR

nuclear magnetic resonance

PD

Parkinson’s disease

aS

α-synuclein

bS

β-synuclein

gS

γ-synuclein

NAC

non-Aβ amyloid component

SSP

secondary structure propesnsity

HSQC

heteronuclear single quantum correlation spectroscopy

R1

longitudinal relaxation rate

R2

transverse relaxation rate

1H-15N NOE

steady-state heteronuclear NOE

PRE

paramagnetic relaxation enhancement

MTSL

(1-oxy-2,2,5,5-tetra-methyl-3-pyrroline-3-methyl)-methanesulfonate

LOESS

locally weighted scatterplot smoothing method

References

  • 1.Mittag T, Forman-Kay JD. Atomic-level characterization of disordered protein ensembles. Curr Opin Struct Biol. 2007;17:3–14. doi: 10.1016/j.sbi.2007.01.009. [DOI] [PubMed] [Google Scholar]
  • 2.Dyson HJ, Wright PE. Unfolded proteins and protein folding studied by NMR. Chem Rev. 2004;104:3607–22. doi: 10.1021/cr030403s. [DOI] [PubMed] [Google Scholar]
  • 3.Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839–40. doi: 10.1038/42166. [DOI] [PubMed] [Google Scholar]
  • 4.Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies. Proc Natl Acad Sci U S A. 1998;95:6469–73. doi: 10.1073/pnas.95.11.6469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci. 2003;26:267–98. doi: 10.1146/annurev.neuro.26.010302.081142. [DOI] [PubMed] [Google Scholar]
  • 6.Volles MJ, Lansbury PT., Jr Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson’s disease. Biochemistry. 2003;42:7871–8. doi: 10.1021/bi030086j. [DOI] [PubMed] [Google Scholar]
  • 7.Eliezer D, Kutluay E, Bussell R, Jr, Browne G. Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol. 2001;307:1061–73. doi: 10.1006/jmbi.2001.4538. [DOI] [PubMed] [Google Scholar]
  • 8.Bertoncini CW, Jung YS, Fernandez CO, Hoyer W, Griesinger C, Jovin TM, Zweckstetter M. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc Natl Acad Sci U S A. 2005;102:1430–5. doi: 10.1073/pnas.0407146102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dedmon MM, Lindorff-Larsen K, Christodoulou J, Vendruscolo M, Dobson CM. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc. 2005;127:476–7. doi: 10.1021/ja044834j. [DOI] [PubMed] [Google Scholar]
  • 10.Sung YH, Eliezer D. Residual Structure, Backbone Dynamics, and Interactions within the Synuclein Family. J Mol Biol. 2007;372:689–707. doi: 10.1016/j.jmb.2007.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bussell R, Jr, Eliezer D. Residual structure and dynamics in Parkinson’s disease-associated mutants of alpha-synuclein. J Biol Chem. 2001;276:45996–6003. doi: 10.1074/jbc.M106777200. [DOI] [PubMed] [Google Scholar]
  • 12.Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–7. doi: 10.1126/science.276.5321.2045. [DOI] [PubMed] [Google Scholar]
  • 13.Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat Genet. 1998;18:106–8. doi: 10.1038/ng0298-106. [DOI] [PubMed] [Google Scholar]
  • 14.Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55:164–73. doi: 10.1002/ana.10795. [DOI] [PubMed] [Google Scholar]
  • 15.Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT., Jr Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson’s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A. 2000;97:571–6. doi: 10.1073/pnas.97.2.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rochet JC, Conway KA, Lansbury PT., Jr Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. Biochemistry. 2000;39:10619–26. doi: 10.1021/bi001315u. [DOI] [PubMed] [Google Scholar]
  • 17.Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis JC, Wypych J, Biere AL, Citron M. Both familial Parkinson’s disease mutations accelerate alpha-synuclein aggregation. J Biol Chem. 1999;274:9843–6. doi: 10.1074/jbc.274.14.9843. [DOI] [PubMed] [Google Scholar]
  • 18.Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL. alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson’s disease. J Biol Chem. 1999;274:19509–12. doi: 10.1074/jbc.274.28.19509. [DOI] [PubMed] [Google Scholar]
  • 19.Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A. 2000;97:4897–902. doi: 10.1073/pnas.97.9.4897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med. 1998;4:1318–20. doi: 10.1038/3311. [DOI] [PubMed] [Google Scholar]
  • 21.Rasia RM, Bertoncini CW, Marsh D, Hoyer W, Cherny D, Zweckstetter M, Griesinger C, Jovin TM, Fernandez CO. Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson’s disease. Proc Natl Acad Sci U S A. 2005;102:4294–9. doi: 10.1073/pnas.0407881102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ferentz AE, Wagner G. NMR spectroscopy: a multifaceted approach to macromolecular structure. Q Rev Biophys. 2000;33:29–65. doi: 10.1017/s0033583500003589. [DOI] [PubMed] [Google Scholar]
  • 23.Kim S, Szyperski T. GFT NMR, a new approach to rapidly obtain precise high-dimensional NMR spectral information. J Am Chem Soc. 2003;125:1385–93. doi: 10.1021/ja028197d. [DOI] [PubMed] [Google Scholar]
  • 24.Kim S, Szyperski T. GFT NMR experiments for polypeptide backbone and 13Cbeta chemical shift assignment. J Biomol NMR. 2004;28:117–30. doi: 10.1023/B:JNMR.0000013827.20574.46. [DOI] [PubMed] [Google Scholar]
  • 25.Bertoncini CW, Rasia RM, Lamberto GR, Binolfi A, Zweckstetter M, Griesinger C, Fernandez CO. Structural Characterization of the Intrinsically Unfolded Protein beta-Synuclein, a Natural Negative Regulator of alpha-Synuclein Aggregation. J Mol Biol. 2007;372:708–722. doi: 10.1016/j.jmb.2007.07.009. [DOI] [PubMed] [Google Scholar]
  • 26.Marsh JA, Singh VK, Jia Z, Forman-Kay JD. Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation. Protein Sci. 2006;15:2795–804. doi: 10.1110/ps.062465306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Eliezer D, Barre P, Kobaslija M, Chan D, Li X, Heend L. Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation. Biochemistry. 2005;44:1026–36. doi: 10.1021/bi048953n. [DOI] [PubMed] [Google Scholar]
  • 28.Yao J, Dyson HJ, Wright PE. Chemical shift dispersion and secondary structure prediction in unfolded and partly folded proteins. FEBS Lett. 1997;419:285–9. doi: 10.1016/s0014-5793(97)01474-9. [DOI] [PubMed] [Google Scholar]
  • 29.Kim HY, Heise H, Fernandez CO, Baldus M, Zweckstetter M. Correlation of Amyloid Fibril beta-Structure with the Unfolded State of alpha-Synuclein. Chembiochem. 2007;8:1671–1674. doi: 10.1002/cbic.200700366. [DOI] [PubMed] [Google Scholar]
  • 30.Schwalbe H, Fiebig KM, Buck M, Jones JA, Grimshaw SB, Spencer A, Glaser SJ, Smith LJ, Dobson CM. Structural and dynamical properties of a denatured protein. Heteronuclear 3D NMR experiments and theoretical simulations of lysozyme in 8 M urea. Biochemistry. 1997;36:8977–91. doi: 10.1021/bi970049q. [DOI] [PubMed] [Google Scholar]
  • 31.Cleveland WS, Devlin SJ. Locally Weighted Regression:An Approach to Regression Analysis by Local Fitting. Journal of the American Statistical Association. 1988;83:596–610. [Google Scholar]
  • 32.Klein-Seetharaman J, Oikawa M, Grimshaw SB, Wirmer J, Duchardt E, Ueda T, Imoto T, Smith LJ, Dobson CM, Schwalbe H. Long-range interactions within a nonnative protein. Science. 2002;295:1719–22. doi: 10.1126/science.1067680. [DOI] [PubMed] [Google Scholar]
  • 33.Wirmer J, Berk H, Ugolini R, Redfield C, Schwalbe H. Characterization of the unfolded state of bovine alpha-lactalbumin and comparison with unfolded states of homologous proteins. Protein Sci. 2006;15:1397–407. doi: 10.1110/ps.051974506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kroenke CD, Loria JP, Lee LK, Rance M, Palmer AG. Longitudinal and Transverse 1H-15N Dipolar/15N Chemical Shift Anisotropy Relaxation Interference: Unambiguous Determination of Rotational Diffusion Tensors and Chemical Exchange Effects in Biological Macromolecules. J Am Chem Soc. 1998;120:7905–7915. [Google Scholar]
  • 35.Tjandra N, Szabo A, Bax A. Protein Backbone Dynamics and 15N Chemical Shift Anisotropy from Quantitative Measurement of Relaxation Interference Effects. J Am Chem Soc. 1996;118:6986–6991. [Google Scholar]
  • 36.Wang C, Palmer AG., 3rd Solution NMR methods for quantitative identification of chemical exchange in 15N-labeled proteins. Magnetic Resonance in Chemistry. 2003;41:866–876. [Google Scholar]
  • 37.Wang C, Grey MJ, Palmer AG., 3rd CPMG sequences with enhanced sensitivity to chemical exchange. J Biomol NMR. 2001;21:361–6. doi: 10.1023/a:1013328206498. [DOI] [PubMed] [Google Scholar]
  • 38.Wu DH, Chen AD, Johnson CS. An Improved Diffusion-Ordered Spectroscopy Experiment Incorporating Bipolar-Gradient Pulses. Journal of Magnetic Resonance, Series A. 1995;115:260–264. [Google Scholar]
  • 39.Munishkina LA, Henriques J, Uversky VN, Fink AL. Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation. Biochemistry. 2004;43:3289–300. doi: 10.1021/bi034938r. [DOI] [PubMed] [Google Scholar]
  • 40.Hoyer W, Cherny D, Subramaniam V, Jovin TM. Impact of the acidic C-terminal region comprising amino acids 109–140 on alpha-synuclein aggregation in vitro. Biochemistry. 2004;43:16233–42. doi: 10.1021/bi048453u. [DOI] [PubMed] [Google Scholar]
  • 41.Li W, West N, Colla E, Pletnikova O, Troncoso JC, Marsh L, Dawson TM, Jakala P, Hartmann T, Price DL, Lee MK. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson’s disease-linked mutations. Proc Natl Acad Sci U S A. 2005;102:2162–7. doi: 10.1073/pnas.0406976102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bertoncini CW, Fernandez CO, Griesinger C, Jovin TM, Zweckstetter M. Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation. J Biol Chem. 2005;280:30649–52. doi: 10.1074/jbc.C500288200. [DOI] [PubMed] [Google Scholar]
  • 43.Kessler JC, Rochet JC, Lansbury PT., Jr The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry. 2003;42:672–8. doi: 10.1021/bi020429y. [DOI] [PubMed] [Google Scholar]
  • 44.Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT., Jr NACP, a protein implicated in Alzheimer’s disease and learning, is natively unfolded. Biochemistry. 1996;35:13709–15. doi: 10.1021/bi961799n. [DOI] [PubMed] [Google Scholar]
  • 45.Mills JL, Szyperski T. Protein dynamics in supercooled water: the search for slow motional modes. J Biomol NMR. 2002;23:63–7. doi: 10.1023/a:1015397305148. [DOI] [PubMed] [Google Scholar]
  • 46.Skalicky JJ, Mills JL, Sharma S, Szyperski T. Aromatic ring-flipping in supercooled water: implications for NMR-based structural biology of proteins. J Am Chem Soc. 2001;123:388–97. doi: 10.1021/ja003220l. [DOI] [PubMed] [Google Scholar]
  • 47.Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6:277–93. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
  • 48.Johnson BA, Blevins RA. NMR View: A computer program for the visualization and analysis of NMR data. Journal of Biomolecular NMR. 1994;4:603–614. doi: 10.1007/BF00404272. [DOI] [PubMed] [Google Scholar]
  • 49.Goddard TD, Kneller DG. Sparky 3. University of California; San Francisco: [Google Scholar]
  • 50.Wishart DS, Case DA, Thomas L, James VDUS. Methods in Enzymology. Vol. 338. Academic Press; 2002. Use of chemical shifts in macromolecular structure determination; pp. 3–34. [DOI] [PubMed] [Google Scholar]
  • 51.Farrow NA, Muhandiram R, Singer AU, Pascal SM, Kay CM, Gish G, Shoelson SE, Pawson T, Forman-Kay JD, Kay LE. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry. 1994;33:5984–6003. doi: 10.1021/bi00185a040. [DOI] [PubMed] [Google Scholar]
  • 52.Jerschow A, Muller N. Suppression of Convection Artifacts in Stimulated-Echo Diffusion Experiments. Double-Stimulated-Echo Experiments. J Magn Reson B. 1997;125:372–375. [Google Scholar]
  • 53.Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM. The Xplor-NIH NMR molecular structure determination package. J Magn Reson. 2003;160:65–73. doi: 10.1016/s1090-7807(02)00014-9. [DOI] [PubMed] [Google Scholar]
  • 54.Fieber W, Kristjansdottir S, Poulsen FM. Short-range, long-range and transition state interactions in the denatured state of ACBP from residual dipolar couplings. J Mol Biol. 2004;339:1191–9. doi: 10.1016/j.jmb.2004.04.037. [DOI] [PubMed] [Google Scholar]

RESOURCES